AnaptysBio, Inc. (FRA:AN6)
37.80
+1.20 (3.28%)
At close: Dec 5, 2025
AnaptysBio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -84.63 | -145.23 | -163.62 | -128.72 | -57.8 | -19.93 | Upgrade
|
| Depreciation & Amortization | 2.42 | 2.4 | 2.38 | 2.34 | 2.09 | 1.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.02 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -6.7 | -10.31 | -10.52 | -2.51 | 0.49 | 0.46 | Upgrade
|
| Stock-Based Compensation | 35.75 | 34.05 | 33.21 | 27.36 | 15.35 | 11.5 | Upgrade
|
| Other Operating Activities | 77.59 | 50.09 | 18.08 | 21.11 | 1.45 | - | Upgrade
|
| Change in Accounts Receivable | -63.49 | -33.91 | -5.43 | -0.54 | -0.88 | - | Upgrade
|
| Change in Accounts Payable | -104.96 | -33.84 | 10.94 | 9.7 | -4.74 | -7.69 | Upgrade
|
| Change in Other Net Operating Assets | -0.95 | 1.43 | -5.83 | -2.32 | -1.87 | -0.14 | Upgrade
|
| Operating Cash Flow | -144.97 | -135.34 | -120.8 | -73.59 | -45.92 | -14.16 | Upgrade
|
| Capital Expenditures | -0.35 | -0.36 | -0.81 | -0.36 | -1.37 | -0.57 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.02 | - | Upgrade
|
| Investment in Securities | 125.49 | 95.76 | 145.56 | -394.49 | 40.19 | 95.04 | Upgrade
|
| Investing Cash Flow | 125.14 | 95.4 | 144.75 | -394.85 | 38.84 | 94.48 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -1.38 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -1.38 | Upgrade
|
| Issuance of Common Stock | 2.6 | 100.84 | 2.47 | 11.83 | 2.55 | 0.5 | Upgrade
|
| Repurchase of Common Stock | -65.7 | -0.46 | -50 | - | - | - | Upgrade
|
| Other Financing Activities | 1.18 | 26.67 | -11.77 | 32.19 | 249.75 | - | Upgrade
|
| Financing Cash Flow | -61.91 | 127.05 | -59.3 | 44.02 | 252.3 | -0.88 | Upgrade
|
| Net Cash Flow | -81.75 | 87.12 | -35.34 | -424.42 | 245.21 | 79.44 | Upgrade
|
| Free Cash Flow | -145.32 | -135.7 | -121.61 | -73.95 | -47.29 | -14.73 | Upgrade
|
| Free Cash Flow Margin | -85.75% | -148.66% | -708.79% | -718.88% | -74.85% | -19.63% | Upgrade
|
| Free Cash Flow Per Share | -4.94 | -4.78 | -4.52 | -2.63 | -1.72 | -0.54 | Upgrade
|
| Cash Interest Paid | 56.93 | - | - | - | - | 0 | Upgrade
|
| Levered Free Cash Flow | -97.65 | -89.79 | -73.42 | -46.19 | -28.1 | -9.59 | Upgrade
|
| Unlevered Free Cash Flow | -49.16 | -58.49 | -62.12 | -33 | -27.19 | -9.59 | Upgrade
|
| Change in Working Capital | -169.4 | -66.33 | -0.32 | 6.84 | -7.49 | -7.83 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.